Cell and Organ Transplantology. 2020; 8(1):76-80.
DOI: 10.22494/cot.v8i1.107
Stem cells transplantation in the treatment of patients with cerebral palsy
Petriv T.1,2,3, Tatarchuk M.1
, Tsymbaliuk Ya.1
, Tsymbaliuk Yu.1
, Tsymbaliuk V.4
- 1Romodanov State Institute of Neurosurgery of the National Academy of Medical Sciences of Ukraine, Department of Reconstructive Neurosurgery with X-ray surgery, Kyiv, Ukraine
- 2Medical Center Hemafund, LTD, Kyiv, Ukraine
- 3QR Health Solutions, Kyiv, Ukraine
- 4National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
Abstract
Cerebral palsy remains a significant problem today, despite scientific and technological progress. The high degree of disability and unsatisfactory quality of life of patients in this category, necessitates the search for and implementation of the latest treatments, one of which is cell transplantation. The use of regenerative cell technologies in the treatment of patients with cerebral palsy is extremely promising. Numerous experimental studies have significantly expanded the understanding of the mechanisms of the effect of the use of stem cells in cerebral palsy. Clinical applications of stem cells of different origins are safe, which is one of the prerequisites for continuing research in this area.
This review is devoted to the use of regenerative cell technologies in the treatment of cerebral palsy, the current state and prospects of the approach to the treatment of cerebral palsy with stem cells.
Key words: stem cells, cell therapy, cerebral palsy
Full Text PDF (eng) Full Text PDF (ua)
1. Nakaz MOZ №286 vid 09.04.2013р. “Pro zatverdzhennya ta vprovadzhennya mediko-tekhnologіchnih dokumentіv zі standartizacії medichnoї dopomogi pri organіchnih urazhennyah golovnogo mozku u dіtej, yakі suprovodzhuyut’sya ruhovimi porushennyami” [in Ukrainian]. | ||||
2. Kabacij M. S. Goshko V. Yu.; Seker T. M. Likuvannya spasty’chny’x form dy’tyachogo cerebral’nogo paralichu v ditej na etapax operaty’vnogo vtruchannya. Travma 2016; 17 (3): 166-168. doi:10.22141/1608-1706.3.17.2016.75803 [in Ukrainian]. https://doi.org/10.22141/1608-1706.3.17.2016.75803 |
||||
3. Gulati S, Sondhi V. Cerebral Palsy: An Overview. Indian J Pediatr. 2018;85(11):1006-1016. doi:10.1007/s12098-017-2475-1. https://doi.org/10.1007/s12098-017-2475-1 PMid:29152685 |
||||
4. Lee FK, Lin YL, Wang PH. Mesenchymal stem cells and cerebral palsy. J Chin Med Assoc. 2020;83(4):323-324. doi:10.1097/JCMA.0000000000000263. https://doi.org/10.1097/JCMA.0000000000000263 PMid:31985567 |
||||
5. Fu X, Hua R, Wang X, et al. Synergistic Improvement in Children with Cerebral Palsy Who Underwent Double-Course Human Wharton’s Jelly Stem Cell Transplantation. Stem Cells Int. 2019;2019:7481069. doi:10.1155/2019/7481069. https://doi.org/10.1155/2019/7481069 PMid:31636676 PMCid:PMC6766101 |
||||
6. Boruczkowski D, Zdolińska-Malinowska I. Wharton’s Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study. Stem Cells Int. 2019;2019:7402151. doi:10.1155/2019/7402151. https://doi.org/10.1155/2019/7402151 PMid:31191683 PMCid:PMC6525822 |
||||
7. Nitkin CR, Rajasingh J, Pisano C, Besner GE, Thébaud B, Sampath V. Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges. Pediatr Res. 2020;87(2):265-276. doi:10.1038/s41390-019-0425-5. https://doi.org/10.1038/s41390-019-0425-5 PMid:31086355 PMCid:PMC6854309 |
||||
8. Chang YS, Ahn SY, Sung S, Park WS. Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges. Yonsei Med J. 2017;58(2):266-271. doi:10.3349/ymj.2017.58.2.266. https://doi.org/10.3349/ymj.2017.58.2.266 PMid:28120555 PMCid:PMC5290004 |
||||
9. Domenighetti AA, Mathewson MA, Pichika R, et al. Loss of myogenic potential and fusion capacity of muscle stem cells isolated from contractured muscle in children with cerebral palsy. Am J Physiol Cell Physiol. 2018;315(2):C247-C257. doi:10.1152/ajpcell.00351.2017. https://doi.org/10.1152/ajpcell.00351.2017 PMid:29694232 PMCid:PMC6139501 |
||||
10. Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68. Published 2019 Feb 26. doi:10.1186/s13287-019-1165-5. https://doi.org/10.1186/s13287-019-1165-5 PMid:30808416 PMCid:PMC6390367 |
||||
11. Suman S, Domingues A, Ratajczak J, Ratajczak MZ. Potential Clinical Applications of Stem Cells in Regenerative Medicine. Adv Exp Med Biol. 2019;1201:1-22. doi:10.1007/978-3-030-31206-0_1. https://doi.org/10.1007/978-3-030-31206-0_1 PMid:31898779 |
||||
12. Laplane L, Solary E. Towards a classification of stem cells. Elife. 2019;8:e46563. doi:10.7554/eLife.46563 https://doi.org/10.7554/eLife.46563 PMid:30864951 PMCid:PMC6415933 |
||||
13. Rameshwar P, Moore CA, Shah NN, Smith CP. An Update on the Therapeutic Potential of Stem Cells. Methods Mol Biol. 2018;1842:3-27. doi:10.1007/978-1-4939-8697-2_1. https://doi.org/10.1007/978-1-4939-8697-2_1 PMid:30196398 |
||||
14. Viswanathan S, Shi Y, Galipeau J, et al. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. 2019;21(10):1019-1024. doi:10.1016/j.jcyt.2019.08.002 https://doi.org/10.1016/j.jcyt.2019.08.002 PMid:31526643 |
||||
15. Pіchkur L.D. Nejrohіrurgіchne lіkuvannya hvorih na dityachij cerebral’nij paralіch [disertacіya]. Kiїv (Ukraїna): DU “Іnstitut nejrohіrurgії іm. akad. A.P.Romodanova NAMN Ukraїni”; 2009 [in Ukrainian]. | ||||
16. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11(4):268-277. doi:10.1038/nrc3034. https://doi.org/10.1038/nrc3034 PMid:21390058 |
||||
17. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-872. doi:10.1016/j.cell.2007.11.019. https://doi.org/10.1016/j.cell.2007.11.019 PMid:18035408 |
||||
18. Godini R, Lafta HY, Fallahi H. Epigenetic modifications in the embryonic and induced pluripotent stem cells. Gene Expr Patterns. 2018;29:1-9. doi:10.1016/j.gep.2018.04.001. https://doi.org/10.1016/j.gep.2018.04.001 PMid:29625185 |
||||
19. Berglund S, Magalhaes I, Gaballa A, Vanherberghen B, Uhlin M. Advances in umbilical cord blood cell therapy: the present and the future. Expert Opin Biol Ther. 2017;17(6):691-699. doi:10.1080/14712598.2017.1316713. https://doi.org/10.1080/14712598.2017.1316713 PMid:28379044 |
||||
20. Ruggeri A, Paviglianiti A, Gluckman E, Rocha V. Impact of HLA in cord blood transplantation outcomes. HLA. 2016;87(6):413-421. doi:10.1111/tan.12792. https://doi.org/10.1111/tan.12792 PMid:27060588 |
||||
21. Cavusoglu T, Kilic KD, Yigitturk G, Tomruk C, Turgut M, Uyanikgil Y. Clinical Use and Patentability of Cord Blood. Recent Pat Endocr Metab Immune Drug Discov. 2017;11(1):13-21. doi:10.2174/1872214812666180314121241. https://doi.org/10.2174/1872214812666180314121241 PMid:29542426 |
||||
22. Polymeri A, Giannobile WV, Kaigler D. Bone Marrow Stromal Stem Cells in Tissue Engineering and Regenerative Medicine. Horm Metab Res. 2016;48(11):700-713. doi:10.1055/s-0042-118458. https://doi.org/10.1055/s-0042-118458 PMid:27871114 |
||||
23. Lagarkova MA. Such Various Stem Cells. Biochemistry (Mosc). 2019;84(3):187-189. doi:10.1134/S0006297919030015. https://doi.org/10.1134/S0006297919030015 PMid:31221057 |
||||
24. Galipeau J, Sensébé L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018;22(6):824-833. doi:10.1016/j.stem.2018.05.004. https://doi.org/10.1016/j.stem.2018.05.004 PMid:29859173 PMCid:PMC6434696 |
||||
25. Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal Stem Cell Migration and Tissue Repair. Cells. 2019;8(8):784. doi:10.3390/cells8080784. https://doi.org/10.3390/cells8080784 PMid:31357692 PMCid:PMC6721499 |
||||
26. Guadix JA, Zugaza JL, Gálvez-Martín P. Characteristics, applications and prospects of mesenchymal stem cells in cell therapy. Características, aplicaciones y perspectivas de las células madre mesenquimales en terapia celular. Med Clin (Barc). 2017;148(9):408-414. doi:10.1016/j.medcli.2016.11.033. https://doi.org/10.1016/j.medcli.2016.11.033 PMid:28126234 |
||||
27. Marofi F, Vahedi G, Hasanzadeh A, et al. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality? J Cell Physiol. 2019;234(2):1268-1288. doi:10.1002/jcp.27152. https://doi.org/10.1002/jcp.27152 PMid:30191962 |
||||
28. Shigemoto-Mogami Y, Hoshikawa K, Goldman JE, Sekino Y, Sato K. Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J Neurosci. 2014;34(6):2231-2243. doi:10.1523/JNEUROSCI.1619-13.2014. https://doi.org/10.1523/JNEUROSCI.1619-13.2014 PMid:24501362 PMCid:PMC3913870 |
||||
29. Liu JA, Cheung M. Neural crest stem cells and their potential therapeutic applications. Dev Biol. 2016;419(2):199-216. doi:10.1016/j.ydbio.2016.09.006. https://doi.org/10.1016/j.ydbio.2016.09.006 PMid:27640086 |
||||
30. Kosykh A, Beilin A, Sukhinich K, Vorotelyak E. Postnatal neural crest stem cells from hair follicle interact with nerve tissue in vitro and in vivo. Tissue Cell. 2018;54:94-104. doi:10.1016/j.tice.2018.08.005. https://doi.org/10.1016/j.tice.2018.08.005 PMid:30309515 |
||||
31. Hofer HR, Tuan RS. Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther. 2016;7(1):131. doi:10.1186/s13287-016-0394-0 https://doi.org/10.1186/s13287-016-0394-0 PMid:27612948 PMCid:PMC5016979 |
||||
32. Wang S, Zhu R, Li H, Li J, Han Q, Zhao RC. Mesenchymal stem cells and immune disorders: from basic science to clinical transition. Front Med. 2019;13(2):138-151. doi:10.1007/s11684-018-0627-y. https://doi.org/10.1007/s11684-018-0627-y PMid:30062557 |
||||
33. Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M. Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration. Tissue Eng Part B Rev. 2017;23(6):515-528. doi:10.1089/ten.TEB.2016.0365. https://doi.org/10.1089/ten.teb.2016.0365 PMid:28490258 |
||||
34. Abbaspanah B, Momeni M, Ebrahimi M, Mousavi SH. Advances in perinatal stem cells research: a precious cell source for clinical applications. Regen Med. 2018;13(5):595-610. doi:10.2217/rme-2018-0019 https://doi.org/10.2217/rme-2018-0019 PMid:30129876 |
||||
35. Ma T, Wang X, Jiang D. Immune Tolerance of Mesenchymal Stem Cells and Induction of Skin Allograft Tolerance. Curr Stem Cell Res Ther. 2017;12(5):409-415. doi:10.2174/1574888X12666170301122744. https://doi.org/10.2174/1574888X12666170301122744 PMid:28260519 |
||||
36. Chirba MA, Sweetapple B, Hannon CP, Anderson JA. FDA regulation of adult stem cell therapies as used in sports medicine. J Knee Surg. 2015;28(1):55-62. doi:10.1055/s-0034-1398470. https://doi.org/10.1055/s-0034-1398470 PMid:25603042 |
||||
37. Wang Y, Tian M, Wang F, et al. Understanding the Immunological Mechanisms of Mesenchymal Stem Cells in Allogeneic Transplantation: From the Aspect of Major Histocompatibility Complex Class I. Stem Cells Dev. 2019;28(17):1141-1150. doi:10.1089/scd.2018.0256. https://doi.org/10.1089/scd.2018.0256 PMid:31215341 |
||||
38. Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74(13):2345-2360. doi:10.1007/s00018-017-2473-5. https://doi.org/10.1007/s00018-017-2473-5 PMid:28214990 |
||||
39. Kiaie N, Aghdam RM, Tafti SHA, Gorabi AM. Stem Cell-Mediated Angiogenesis in Tissue Engineering Constructs. Curr Stem Cell Res Ther. 2019;14(3):249-258. doi:10.2174/1574888X13666181105145144. https://doi.org/10.2174/1574888X13666181105145144 PMid:30394215 |
||||
40. Munir H, Ward LSC, McGettrick HM. Mesenchymal Stem Cells as Endogenous Regulators of Inflammation. Adv Exp Med Biol. 2018;1060:73-98. doi:10.1007/978-3-319-78127-3_5. https://doi.org/10.1007/978-3-319-78127-3_5 PMid:30155623 |
||||
41. Ko HR, Ahn SY, Chang YS, et al. Human UCB-MSCs treatment upon intraventricular hemorrhage contributes to attenuate hippocampal neuron loss and circuit damage through BDNF-CREB signaling. Stem Cell Res Ther. 2018;9(1):326. doi:10.1186/s13287-018-1052-5. https://doi.org/10.1186/s13287-018-1052-5 PMid:30463591 PMCid:PMC6249960 |
||||
42. Gobshtis N, Tfilin M, Wolfson M, Fraifeld VE, Turgeman G. Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid. Oncotarget. 2017;8(11):17443-17452. doi:10.18632/oncotarget.15245. https://doi.org/10.18632/oncotarget.15245 PMid:28407680 PMCid:PMC5392261 |
||||
43. Yarmolyuk E.S. Vpliv tkaninnoї transplantacії na angіogenez v dіlyancі іshemіchnogo ushkodzhennya golovnogo mozku v eksperimentі [disertacіya]. Kiїv (Ukraїna): Іnstitut nejrohіrurgії іm. akad. A. P. Romodanova NAMN Ukraїni; 2016 [in Ukrainian]. | ||||
44. Gu J, Huang L, Zhang C, et al. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial. Stem Cell Res Ther. 2020;11(1):43. Published 2020 Feb 3. doi:10.1186/s13287-019-1545-x. https://doi.org/10.1186/s13287-019-1545-x PMid:32014055 PMCid:PMC6998370 |
||||
45. Elgaz S, Kuçi Z, Kuçi S, Bönig H, Bader P. Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease. Transfus Med Hemother. 2019;46(1):27-34. doi:10.1159/000496809. https://doi.org/10.1159/000496809 PMid:31244579 PMCid:PMC6558336 |
||||
46. Xie B, Chen M, Hu R, Han W, Ding S. Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials. Stem Cells Int. 2020;2020:5701920. doi:10.1155/2020/5701920/ https://doi.org/10.1155/2020/5701920 PMid:32765613 PMCid:PMC7387980 |
||||
47. Wang X, Hu H, Hua R, et al. Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors. Cytotherapy. 2015;17(2):224-231. doi:10.1016/j.jcyt.2014.09.010/ https://doi.org/10.1016/j.jcyt.2014.09.010 PMid:25593078 |
||||
48. Fu X, Hua R, Wang X, et al. Synergistic Improvement in Children with Cerebral Palsy Who Underwent Double-Course Human Wharton’s Jelly Stem Cell Transplantation. Stem Cells Int. 2019;2019:7481069. Published 2019 Sep 17. doi:10.1155/2019/7481069. https://doi.org/10.1155/2019/7481069 PMid:31636676 PMCid:PMC6766101 |
||||
49. Sun JM, Song AW, Case LE, et al. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. Stem Cells Transl Med. 2017;6(12):2071-2078. doi:10.1002/sctm.17-0102/ | ||||
50. Chen G, Wang Y, Xu Z, et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J Transl Med. 2013;11:21. Published 2013 Jan 26. doi:10.1186/1479-5876-11-21/ https://doi.org/10.1186/1479-5876-11-21 PMid:23351389 PMCid:PMC3563497 |
||||
51. Min K, Song J, Kang JY, et al. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial. Stem Cells. 2013;31(3):581-591. doi:10.1002/stem.1304/ https://doi.org/10.1002/stem.1304 PMid:23281216 PMCid:PMC3744768 |
||||
52. Miao X, Wu X, Shi W. Umbilical cord mesenchymal stem cells in neurological disorders: A clinical study. Indian J Biochem Biophys. 2015;52(2):140-146. | ||||
53. Novak I, Walker K, Hunt RW, Wallace EM, Fahey M, Badawi N. Concise Review: Stem Cell Interventions for People With Cerebral Palsy: Systematic Review With Meta-Analysis. Stem Cells Transl Med. 2016;5(8):1014-1025. doi:10.5966/sctm.2015-0372. https://doi.org/10.5966/sctm.2015-0372 PMid:27245364 PMCid:PMC4954458 |
||||
54. Eggenberger S, Boucard C, Schoeberlein A, et al. Stem cell treatment and cerebral palsy: Systemic review and meta-analysis. World J Stem Cells. 2019;11(10):891-903. doi:10.4252/wjsc.v11.i10.891. https://doi.org/10.4252/wjsc.v11.i10.891 PMid:31692977 PMCid:PMC6828595 |
Petriv T, Tatarchuk M, Tsymbaliuk Ya, Tsymbaliuk Yu, Tsymbaliuk V. Stem cells transplantation in the treatment of patients with cerebral palsy. Cell Organ Transpl. 2020; 8(1):76-80. doi:10.22494/cot.v8i1.107
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.